EMPAA M XR 12.5MG 1000MG TAB

Empaa M XR 12.5mg/1000mg Tablet – Dual Action Diabetes Control with Empagliflozin & Metformin

Empaa M XR is an advanced combination oral medication containing Empagliflozin 12.5mg and Metformin Hydrochloride Extended Release (XR) 1000mg, used for the effective management of Type 2 Diabetes Mellitus. This once-daily formulation helps lower blood sugar, reduce cardiovascular risk, and support weight management in diabetic patients.

Key Features:

• ✅ Contains Empagliflozin 12.5mg + Metformin XR 1000mg

• ✅ Provides dual mechanism for better blood glucose control

• ✅ Helps lower HbA1c levels effectively

• ✅ Supports weight loss and reduces blood pressure

• ✅ Offers cardiovascular and renal protection in T2DM patients

• ✅ Extended-release formula for longer action and reduced GI upset

How Empaa M XR Works:

• Empagliflozin (SGLT2 inhibitor): Promotes glucose excretion through urine by blocking reabsorption in the kidneys.

• Metformin XR: Reduces hepatic glucose production and improves insulin sensitivity without causing weight gain.

Together, they provide comprehensive glycemic control with added metabolic and cardiovascular benefits.

Directions for Use:

Take once daily with food, preferably in the evening or as prescribed by your physician. Do not crush or chew the tablet.

Important Notes:

• For use in Type 2 Diabetes only

• Prescription-only medication – monitor kidney function and blood sugar regularly

• Not suitable for Type 1 Diabetes or diabetic ketoacidosis